SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.67
arrow_downward
-2.34%(-0.040) 1D
$1.62
arrow_downward
-3.19% (-0.053)todayPre-market
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.68
High
$1.69
Low
$1.60
Mkt. cap
951.94K
Avg. vol.
139.46K
Volume
160.00
52-wk high
$16.40
52-wk low
$1.60
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
Open
$1.68
High
$1.69
Low
$1.60
Mkt. cap
951.94K
Avg. vol.
139.46K
Volume
160.00
52-wk high
$16.40
52-wk low
$1.60
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
Stock Titan
·
2 days ago
A drug deal ends while Scinai reports about $3.1 million in orders
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR